Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

Clinical trial NCT02312557 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02312557
Sponsor: OHSU Knight Cancer Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Castration-Resistant Prostate Carcinoma Hormone-Resistant Prostate Cancer PSA Progression Recurrent Prostate Carcinoma Stage IV Prostate Adenocarcinoma Cancer AJCC v8

Start date: 2014-11-18
Primary completion: 2024-08-22
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.